Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants

Clinical trial NCT06417229 · COMPLETED

Trial details

NCT number: NCT06417229
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2024-05-28
Primary completion: 2025-02-19
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.